SalMar Raises 2026 Volume Guidance on Record Biological Performance

SalMar ASA, one of Norway's largest salmon farming companies, reported a robust first quarter with significant operational improvements and raised its full-year volume guidance, signaling strong momentum in its core Norwegian operations despite headwinds in international subsidiaries.

The company delivered operational EBIT of 1,512 million NOK for the group in Q1 2026, with its Norwegian segment generating 1,536 million NOK—demonstrating the strength of its domestic operations. Buoyed by what management described as "record-strong biological performance metrics," SalMar increased its 2026 volume guidance by 12,000 tons, now targeting 282,000 tons for Norway specifically and 330,000 tons across the entire group, representing approximately 10% growth compared to 2025 levels.

Key Details: Strong Norway Performance Offset by International Challenges

The guidance increase reflects improved operational execution and favorable biological conditions in SalMar's primary Norwegian farming facilities. The company's decision to raise volumes despite inflationary pressures underscores confidence in both production capabilities and market demand for premium Atlantic salmon.

However, the results reveal a two-tier performance story:

• Norwegian operations: Delivering exceptional biological performance and supporting volume growth
• International subsidiaries: Facing significant headwinds from elevated supply chain costs
• Icelandic Salmon: Underperforming due to logistics and operational cost pressures
• Scottish Sea Farms: Similarly struggling with high supply chain expenses impacting profitability

The weakness in Iceland and Scotland—traditionally important production centers for diversified supply—represents a meaningful offset to the Norwegian success story. These geographic challenges highlight the sector's vulnerability to regional cost inflation and logistical disruptions, factors that have plagued global aquaculture operations since 2021.

Market Context: Navigating Structural Headwinds in Global Salmon Markets

The salmon farming industry remains in recovery mode, with SalMar's cautious international expansion contrasting sharply with its Norwegian growth emphasis. This geographic focus reflects broader structural realities:

Sector-Wide Dynamics:

• Supply chain normalization remains incomplete for non-Norwegian operations
• Input costs, particularly feed and energy, continue elevated in high-cost jurisdictions
• Norwegian facilities benefit from established infrastructure and competitive operational cost bases
• Global salmon demand remains robust, particularly from Asian and North American markets

The timing of SalMar's guidance raise—with a 10% year-over-year growth target—positions the company favorably within a recovering market. Competitors like Mowi ASA ($MOWI) and Lerøy Seafood Group face similar international cost pressures, making Norwegian-focused producers relatively advantaged. The company's ability to achieve record biological performance suggests improving animal health and operational execution, critical differentiators in a commoditized market where per-unit margins depend heavily on production efficiency.

Notably, SalMar's Norwegian success occurs against backdrop of regulatory scrutiny on sea lice management, escapement prevention, and environmental standards—areas where strong biological metrics indicate operational compliance and sustainability performance.

Investor Implications: Guidance Raise Signals Confidence Despite Mixed Results

For SalMar shareholders, the volume guidance increase represents management confidence in both near-term operations and medium-term production capacity. A 12,000-ton upside to Norwegian guidance—reaching 282,000 tons—assumes sustained biological performance and successful harvest execution throughout 2026. At current Atlantic salmon prices (typically ranging 50-65 NOK per kilogram in wholesale markets), this incremental volume could represent 600-780 million NOK in additional revenue at baseline assumptions.

However, investors must contend with several countervailing factors:

Positive Signals:

• Record biological performance reduces future disease and mortality risks
• Norwegian operations demonstrate pricing power and operational leverage
• 10% group-level growth targets achievable within existing capacity footprint
• Strong Q1 EBIT margins suggest improving cost structure

Risk Factors:

• Icelandic and Scottish operations remain unprofitable or marginally profitable
• Supply chain cost inflation may persist through 2026
• Currency headwinds (NOK strength) could impact international earnings translation
• Regulatory pressures on environmental metrics could constrain future volume growth

The mixed geographic performance suggests that SalMar, despite strong Norwegian credentials, remains exposed to operational and cost challenges outside its home market. For comparative context, larger integrated producers like Mowi benefit from greater diversification, while pure-play Norwegian producers like SalMar may offer higher upside but with concentrated geographic risk.

SalMar's guidance raise demonstrates that strong biological performance—increasingly recognized as a critical competitive advantage—translates into concrete volume and margin expansion. Investors focused on salmon exposure may view this as a buying signal for quality operators, though the international subsidiary challenges warrant monitoring through successive quarterly reports.

Looking ahead, SalMar's ability to replicate Norwegian success internationally, while maintaining biological excellence and navigating cost inflation, will determine whether 2026 emerges as an inflection point for the company or a peak cycle year. The market will scrutinize execution on the increased volume guidance and closely watch international subsidiary performance in coming quarters.